Regeneron Pharmaceuticals, Inc. REGN
Set alert
961.26 USD +33.37 +3.60%
At close
963.23 +1.97 +0.20%
Pre-market · Nov 3, 5:19 AM ET
927.00 Day range 974.00
591.52 52-week range 974.00
- YTD
- +24.54%
- 1 year
- +47.48%
- Open
- 927.22
- Prev close
- 927.89
- Mkt cap
- 99.44B
- Vol
- 1.66M
- Avg vol
- 733.95K
- EPS
- 45.24
- P/E
- 21.25
- Div yield
- 0.41%
More statistics
- Low
- 927.00
- High
- 974.00
- Forward P/E
- 13.72
- Beta
- 0.10
- Short ratio
- 2.78
- Inst. own
- 93.25%
- Dividend
- 3.76
- Ex-div date
- Nov 19, 2026
- Earnings
- Jan 28, 2027
- 50-d avg
- 793.30
- 200-d avg
- 737.54
- 1y target
- 961.96
6M chart
Events in this range
- May 20, 2026Dividend: 0.94
- Jul 30, 2026Earnings: 14.29; estimate 10.16; surprise 40.65%
- Aug 18, 2026Dividend: 0.94
- Oct 30, 2026Earnings: 20.07; estimate 16.51; surprise 21.56%
- Nov 2, 2026Rating: Guggenheim · Buy → Buy
- Nov 2, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Nov 2, 2026Rating: Truist Securities · Buy → Buy
- Nov 2, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Nov 2, 2026Rating: Bernstein · Market Perform → Market Perform
- Nov 2, 2026Rating: Leerink Partners · Market Perform → Market Perform
Signals (18)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| RSI: Overbought | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| RSI: Overbought | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 23, 2026 | 3 months ago |
| SMA: Bullish | Jul 7, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 5, 2026 | 5 months ago |
| RSI: Oversold | May 27, 2026 | 5 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| RSI: Oversold | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 961.96 +0.1% upside
Now 961.26
- Target (low)
- 730.00
- Target (mean)
- 961.96
- Target (high)
- 1,175.00
Ratings (0m) 28 19 buy · 8 hold · 1 sell
- Strong buy4
- Buy15
- Hold8
- Sell0
- Strong sell1
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 27
- 3 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 25.07 | 17.70 – 30.44 | 11.44 | +119.1% | 5.84B | +50.5% | 22 |
| Next quarter | 15.33 | 9.56 – 18.80 | 9.47 | +61.9% | 4.57B | +26.8% | 9 |
| Current year | 67.50 | 56.63 – 74.53 | 44.31 | +52.3% | 17.60B | +22.7% | 25 |
| Next year | 60.61 | 52.17 – 73.76 | 58.59 | +3.5% | 19.82B | +12.6% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Nov 2, 2026 | Bernstein | Maintained | Market Perform | Market Perform |
| Nov 2, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 2, 2026 | Truist Securities | Maintained | Buy | Buy |
| Nov 2, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Nov 2, 2026 | Guggenheim | Maintained | Buy | Buy |
| Nov 2, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Nov 2, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Nov 2, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 2, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Nov 2, 2026 | Baird | Maintained | Neutral | Neutral |
| Nov 2, 2026 | B of A Securities | Maintained | Buy | Buy |
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 28, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 19, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 15, 2026 | UBS | Upgrade | Neutral | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 7, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 1, 2026 | Jefferies | Maintained | Buy | Buy |
| Oct 1, 2026 | Argus Research | Upgrade | Hold | Buy |
| Sep 29, 2026 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Sep 10, 2026 | HSBC | Maintained | Buy | Buy |
| Aug 17, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 3, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 31, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |